U.S. Supreme Court
Mar. 22, 2012
Supreme court rejects patents for diagnostic medical tests
In a unanimous decision that could send shock waves through California's personalized medicine industry, the U.S. Supreme Court ruled Tuesday that a San Diego laboratory's diagnostic test is ineligible for patent protection.
Daily Journal Staff Writer
WASHINGTON - In a unanimous decision that could send shock waves through California's personalized medicine industry, the U.S. Supreme Court ruled Tuesday that a San Diego laboratory's diagnostic test is ineligible for patent protection.
The court held that the core subject matter of Prometheus Inc.'s test - the body's reaction to a drug - is an unpatentable "law of nature."...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In